Molecular imaging to quantify tumor receptor activity has incredible potential for imaging extracellular protein signaling, yet many ligand molecules cannot be used effectively, because they do not differentiate between simple vascular permeability based uptake and true receptor binding. The development of methodologies which allow quantitative uptake of molecules in tumors is a primary focus of this grant in the renewal period. Fluorescence imaging of receptor activity in vivo is done using a novel Magnetic Resonance-guided Optical (MRgO) imaging instrument that is customized for small animals, with a primary focus on glioma tumor studies. The hardware and software sub- systems will be developed further to provide 4 layer volumetric data of fluorescence tomography guided by the MR data, and overlayed for visualization of the entire orthotopic tumor. The goal of this work is to analyze how molecular tracers of glioma tumors can be used to effectively quantify tumor receptor activity, in addition to vascular perfusion from contrast MRI. The small molecule epidermal growth factor (EGF) is used as a probe in conjunction with a non-specific fluorophore agent to show that ratiometric measurements of the uptake could lead to quantification of the bound EGF Receptor uptake. Glioma tumors that are microinvasive and therefore are not detectable with typical MR imaging can be detected with this new probe molecule, and the dual probe method will be used to show how MRgO imaging can provide a fundamentally new method to image this disease. The design of high and low affinity probes of difference molecular weights for ratiometric imaging is studied in the system with ex vivo validation, to confirm that the in vivo images are truly reflective of the tissue concentration levels. The project ends with the study of microinvasion and testing the detection of this spontaneously and in the setting of anti-vascular therapy. The grant focuses on the technology development, methodology development about how optical fluorescence can be added usefully to imaging science, with these two potential applications in cancer.

Public Health Relevance

Molecular imaging of tumor receptor activity would allow the ability to visualize tumor function, as well as the structural features that are seen with MRI. In this grant, a novel MR-guided optical (MRgO) fluorescence imaging system is used to develop and study methodologies which will allow quantitative receptor imaging of glioma tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109558-10
Application #
8911782
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Nordstrom, Robert J
Project Start
2004-07-01
Project End
2017-07-31
Budget Start
2015-08-01
Budget End
2017-07-31
Support Year
10
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Engineering (All Types)
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
Bruza, Petr; Andreozzi, Jacqueline M; Gladstone, David J et al. (2017) Online Combination of EPID & Cherenkov Imaging for 3-D Dosimetry in a Liquid Phantom. IEEE Trans Med Imaging 36:2099-2103
Elliott, Jonathan T; Marra, Kayla; Evans, Linton T et al. (2017) SimultaneousIn VivoFluorescent Markers for Perfusion, Protoporphyrin Metabolism, and EGFR Expression for Optically Guided Identification of Orthotopic Glioma. Clin Cancer Res 23:2203-2212
Zhang, Rongxiao; Glaser, Adam K; Andreozzi, Jacqueline et al. (2017) Beam and tissue factors affecting Cherenkov image intensity for quantitative entrance and exit dosimetry on human tissue. J Biophotonics 10:645-656
Elliott, Jonathan T; Samkoe, Kimberley S; Davis, Scott C et al. (2016) Image-derived arterial input function for quantitative fluorescence imaging of receptor-drug binding in vivo. J Biophotonics 9:282-95
DSouza, Alisha V; Marra, Kayla; Gunn, Jason R et al. (2016) Optical tracer size differences allow quantitation of active pumping rate versus Stokes-Einstein diffusion in lymphatic transport. J Biomed Opt 21:100501
Pogue, Brian W; Paulsen, Keith D; Samkoe, Kimberley S et al. (2016) Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention. Med Phys 43:3143-3156
Davis, Scott C; Tichauer, Kenneth M (2016) Small-Animal Imaging Using Diffuse Fluorescence Tomography. Methods Mol Biol 1444:123-37
Andreozzi, Jacqueline M; Zhang, Rongxiao; Gladstone, David J et al. (2016) Cherenkov imaging method for rapid optimization of clinical treatment geometry in total skin electron beam therapy. Med Phys 43:993-1002
Lin, Huiyun; Zhang, Rongxiao; Gunn, Jason R et al. (2016) Comparison of Cherenkov excited fluorescence and phosphorescence molecular sensing from tissue with external beam irradiation. Phys Med Biol 61:3955-68
DSouza, Alisha V; Lin, Huiyun; Henderson, Eric R et al. (2016) Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt 21:80901

Showing the most recent 10 out of 77 publications